データなし
データなし
Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to Its Board of Directors
Redhill Biopharma Signed A Collaborative Research Agreement With Duke University School Of Medicine Outlining Plans For Multiple In Vivo Studies, To Test Opaganib As A Potential Medical Countermeasure To Treat Phosgene Inhalation Injury
RedHill Biopharma Advances Opaganib For Ebola Treatment With BARDA Funding, Aiming To Tackle Global Health Preparedness
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Redhill Biopharma Announced The Renewal Of Its Contract With Medi-Cal, California's Medicaid Healthcare Program, To Maintain Talicia's First-line Position On Medi-Cal Fee-For-Service Contract Drug List With No Prior Authorization And A $0 Copay,...
RedHill Biopharma Awarded $733K U.S. HHS BARDA Contract To Investigate Opaganib As Host-Directed Therapeutic For Ebola Virus Disease
データなし
データなし